The surge in jobless claims in early September to a four-year high turns out to have been a false alarm, […]
False alarm: Surge in jobless claims unwinds after recent spike. Layoffs still low. Read Post »
The Wall Street adage — “Sell Rosh Hashana; buy Yom Kippur” — focuses on the market’s performance between these two
This seasonal stock-market trading pattern is coming up — and worth observing Read Post »
The Nvidia investment is the latest source of relief for Intel investors, after the U.S. government took a stake in
Intel’s stock is soaring. Why Nvidia is investing $5 billion in the chip maker. Read Post »
In Europe, there’s a nearly 50-50 split between how frequently companies report, according to Goldman Sachs data.
Do investors care about quarterly vs half-year reporting? Here’s what the numbers say. Read Post »
American Express is seeking to address longstanding customer complaints that it is difficult to track statement credits.
JPMorgan is telling clients to be ready to buy dips, and prepare for a possible explosive move higher for stocks
The wildly popular Ozempic drug cuts heart attack, stroke and death risk by nearly 25% in older patients, according to
Ozempic cuts heart-attack risk by nearly 25% in older patients, new study finds Read Post »
“I have Vanguard stocks valued at about $350,000 and two savings accounts, each of which has $100,000.”
The fact that Fed Chair Jerome Powell classified the rate cut made on Wednesday as one for “risk management” is
‘Risk management’ cuts usually come in pairs, says Goldman economist Read Post »
